Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

December 01, 2015 5:28 AM ET

Healthcare Providers and Services

Company Overview of DIATHERIX Laboratories, Inc.

Company Overview

DIATHERIX Laboratories, Inc., a molecular diagnostic laboratory, offers diagnostic services for detection of infectious diseases. It uses target enriched multiplex polymerase chain reaction technology for precise detection of infectious diseases. The company provides nucleic acid extraction, template addition, and hybridization services. It offers its services to physicians and hospitals. DIATHERIX Laboratories, Inc. was incorporated in 2007 and is based in Huntsville, Alabama. As of June 11, 2015, DIATHERIX Laboratories, Inc. operates as a subsidiary of Eurofins Scientific SA.

601 Genome Way

Suite 4208

Huntsville, AL 35806

United States

Founded in 2007





Key Executives for DIATHERIX Laboratories, Inc.

Chairman and Chief Executive Officer
Age: 59
President and Chief Operating Officer
Chief Financial Officer
Chief Information Officer
Medical Director
Compensation as of Fiscal Year 2015.

DIATHERIX Laboratories, Inc. Key Developments

DIATHERIX Laboratories, Inc. Appoints Ruth W. Brinkley to its Board of Directors

DIATHERIX Laboratories, Inc. announced the appointment of Ruth W. Brinkley, FACHE, to its board of directors. Brinkley has more than 40 years of healthcare experience working in private, public, academic, community-based and healthcare organizations. She currently serves as president and chief executive officer of KentuckyOne Health and as senior vice president of operations for Catholic Health Initiatives.

DIATHERIX Laboratories, Inc. Receives Second Research Contract from FDA and HHS

DIATHERIX Laboratories, Inc. has been awarded a second federal contract to continue its work in the development of research methodologies designed to support the development of diagnostic tools to detect certain low prevalence pathogens. The contract is a joint award from the Food and Drug Administration (FDA) and the Department of Health and Human Services (HHS) to support the development of diagnostic devices/platforms to detect high priority pathogens, as classified by the National Institute of Allergy and Infectious Diseases (NIAID). Diatherix's research focuses on three NIAID pathogens: Francisella tularensis, Escherichia coli, and Babesia microti. Though not prevalent in the natural environment, the pathogens are prioritized by NIAID because of the ease with which they can be disseminated or transmitted; the mortality rates and public health impact they can generate; their potential to cause public panic and social disruption; and the special actions that are required for public health preparedness. For instance, F. tularensis has a low infectious dose, is highly virulent, and is easily spread by aerosol; as such, it is classified by the NIAID and the U.S. Department of Homeland Security as a Category A Priority pathogen/biological agent that poses high risk to national security and public health. The low prevalence of these pathogens complicates the development of diagnostic tools to aid in their detection, as sufficient clinical samples may not be available to conduct the clinical sensitivity studies required for Food and Drug Administration (FDA) clearance. To address this regulatory and scientific challenge, the FDA is exploring the use of "spiked" clinical samples special lab samples in which the pathogen being studied is introduced at increased or enriched levels to support sensitivity studies for the evaluation of diagnostic devices.

Similar Private Companies By Industry

Company Name Region
NHC Place-Charleston, LLC United States
Palmetto Health Baptist Columbia United States
Coventry Health Care of West Virginia, Inc. United States
Hawkeye Care Center Of Carroll,llc United States
Recovery Unlimited, Inc. United States

Recent Private Companies Transactions

June 1, 2015

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact DIATHERIX Laboratories, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at